AXGN AxoGen, Inc. | US05463X1063
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 318.414.560 | 270.881.890 | 17.55% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 0,73 | 0,49 | 49.07% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 6 | 7 | 14.29% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |